LeadIQ logo
Learn more at LeadIQ.com

Insights

Strategic Partnerships AskBio recently partnered with Belief BioMed Inc., showcasing a commitment to collaborations that can open doors for joint sales initiatives and market expansion opportunities.

Market Expansion The expansion of AskBio's offices in Triangle, Virginia, presents a prime opportunity for sales professionals to explore new markets, engage with local stakeholders, and drive business growth in the region.

Key Personnel Addition The appointment of Mansuo Shannon as Chief Scientific Officer signals a focus on innovation and R&D, offering potential sales teams a valuable contact point for discussions around new product developments and strategic partnerships.

Clinical Trials Advancements With ongoing Phase 2 trials and pivotal studies like AB-1005 for Parkinson's disease, AskBio provides a compelling narrative for sales professionals to engage healthcare providers, institutions, and patients, highlighting the benefits of their gene therapies.

Revenue and Growth Potential Given AskBio's substantial revenue and continuous pipeline advancements, sales development representatives can leverage the company's financial stability and innovative products to secure partnerships, investments, and market opportunities.

Similar companies to Asklepios BioPharmaceutical, Inc. (AskBio)

Asklepios BioPharmaceutical, Inc. (AskBio) Tech Stack

Asklepios BioPharmaceutical, Inc. (AskBio) uses 8 technology products and services including Microsoft SharePoint, Microsoft Word, Google Workspace, and more. Explore Asklepios BioPharmaceutical, Inc. (AskBio)'s tech stack below.

  • Microsoft SharePoint
    Content Management System
  • Microsoft Word
    Editors
  • Google Workspace
    Email
  • Microsoft
    Miscellaneous
  • Cogent Communications
    Network Hardware
  • Microsoft Windows Server
    Operating Systems
  • Smartsheet
    Project Management
  • Contact Form 7
    Web Platform Extensions

Media & News

Asklepios BioPharmaceutical, Inc. (AskBio)'s Email Address Formats

Asklepios BioPharmaceutical, Inc. (AskBio) uses at least 1 format(s):
Asklepios BioPharmaceutical, Inc. (AskBio) Email FormatsExamplePercentage
FLast@askbio.comJDoe@askbio.com
96%
FMiddleLast@askbio.comJMichaelDoe@askbio.com
2%
First.Last@askbio.comJohn.Doe@askbio.com
1%
Last.First@askbio.comDoe.John@askbio.com
1%

Frequently Asked Questions

Where is Asklepios BioPharmaceutical, Inc. (AskBio)'s headquarters located?

Minus sign iconPlus sign icon
Asklepios BioPharmaceutical, Inc. (AskBio)'s main headquarters is located at 20 TW Alexander Dr Suite 110 Research Triangle Park, North Carolina 27709 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Asklepios BioPharmaceutical, Inc. (AskBio)'s phone number?

Minus sign iconPlus sign icon
You can contact Asklepios BioPharmaceutical, Inc. (AskBio)'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Asklepios BioPharmaceutical, Inc. (AskBio)'s official website and social media links?

Minus sign iconPlus sign icon
Asklepios BioPharmaceutical, Inc. (AskBio)'s official website is askbio.com and has social profiles on LinkedIn.

How much revenue does Asklepios BioPharmaceutical, Inc. (AskBio) generate?

Minus sign iconPlus sign icon
As of August 2024, Asklepios BioPharmaceutical, Inc. (AskBio)'s annual revenue reached $750M.

What is Asklepios BioPharmaceutical, Inc. (AskBio)'s SIC code NAICS code?

Minus sign iconPlus sign icon
Asklepios BioPharmaceutical, Inc. (AskBio)'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Asklepios BioPharmaceutical, Inc. (AskBio) have currently?

Minus sign iconPlus sign icon
As of August 2024, Asklepios BioPharmaceutical, Inc. (AskBio) has approximately 501 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: G. P.Chief Strategy Officer: R. H.Chief Business Officer And General Counsel: T. D.. Explore Asklepios BioPharmaceutical, Inc. (AskBio)'s employee directory with LeadIQ.

What industry does Asklepios BioPharmaceutical, Inc. (AskBio) belong to?

Minus sign iconPlus sign icon
Asklepios BioPharmaceutical, Inc. (AskBio) operates in the Biotechnology Research industry.

What technology does Asklepios BioPharmaceutical, Inc. (AskBio) use?

Minus sign iconPlus sign icon
Asklepios BioPharmaceutical, Inc. (AskBio)'s tech stack includes Microsoft SharePointMicrosoft WordGoogle WorkspaceMicrosoftCogent CommunicationsMicrosoft Windows ServerSmartsheetContact Form 7.

What is Asklepios BioPharmaceutical, Inc. (AskBio)'s email format?

Minus sign iconPlus sign icon
Asklepios BioPharmaceutical, Inc. (AskBio)'s email format typically follows the pattern of . Find more Asklepios BioPharmaceutical, Inc. (AskBio) email formats with LeadIQ.

How much funding has Asklepios BioPharmaceutical, Inc. (AskBio) raised to date?

Minus sign iconPlus sign icon
As of August 2024, Asklepios BioPharmaceutical, Inc. (AskBio) has raised $2.7M in funding. The last funding round occurred on Sep 02, 2020 for $2.7M.

When was Asklepios BioPharmaceutical, Inc. (AskBio) founded?

Minus sign iconPlus sign icon
Asklepios BioPharmaceutical, Inc. (AskBio) was founded in 2001.
Asklepios BioPharmaceutical, Inc. (AskBio)

Asklepios BioPharmaceutical, Inc. (AskBio)

Biotechnology ResearchNorth Carolina, United States501-1000 Employees

Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene therapy company dedicated to developing life-saving medicines and changing lives. The company maintains a portfolio of clinical programs across a range of neuromuscular, central nervous system, cardiovascular and metabolic disease indications with a clinical-stage pipeline that includes therapeutics for congestive heart failure, Huntington’s disease, limb-girdle muscular dystrophy, multiple system atrophy, Parkinson’s disease, and Pompe disease. AskBio’s gene therapy platform includes Pro10™, an industry-leading proprietary cell line manufacturing process, and an extensive capsid and promoter library. With global headquarters in Research Triangle Park, North Carolina, and European headquarters in Edinburgh, Scotland, the company has generated hundreds of proprietary capsids and promoters, several of which have entered pre-clinical and clinical testing. Learn more at askbio.com. 

Vision - Pioneering science to create transformative molecular medicines.
Mission - Lead innovative science and drive clinical outcomes to transform people's lives.

Values:
• Be a Pioneer. We are not afraid of the impossible and to innovate to make gene therapies accessible to those in need.
• Cultivate Collaboration. Strive to be the best teammate, actively listen, openly communicate, and embrace diverse points of view.
• Embrace Responsibility. We are humbled by the enormity of our mission. We hold a relentless commitment to advance science and clinical outcomes for our patients, families, and caregivers.
• Raise the Bar. Continuously drive improvements and efficiencies. Seek and provide constructive feedback. Have a bias for learning and action.
• Act with Uncompromising Integrity. Be honest, transparent, and committed to doing what’s right in every situation. Make clear commitments and follow through.

Section iconCompany Overview

Headquarters
20 TW Alexander Dr Suite 110 Research Triangle Park, North Carolina 27709 US
Phone number
Website
askbio.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2001
Employees
501-1000

Section iconFunding & Financials

  • $2.7M

    Asklepios BioPharmaceutical, Inc. (AskBio) has raised a total of $2.7M of funding over 4 rounds. Their latest funding round was raised on Sep 02, 2020 in the amount of $2.7M.

  • $100M$1B

    Asklepios BioPharmaceutical, Inc. (AskBio)'s revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $2.7M

    Asklepios BioPharmaceutical, Inc. (AskBio) has raised a total of $2.7M of funding over 4 rounds. Their latest funding round was raised on Sep 02, 2020 in the amount of $2.7M.

  • $100M$1B

    Asklepios BioPharmaceutical, Inc. (AskBio)'s revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.